Literature DB >> 21969156

Hemophagocytic syndrome after liver transplantation: report of two cases.

Akihiko Soyama1, Susumu Eguchi, Mitsuhisa Takatsuki, Masaaki Hidaka, Tetsuo Tomonaga, Kosho Yamanouchi, Kensuke Miyazaki, Takamitsu Inokuma, Yoshitsugu Tajima, Takashi Kanematsu.   

Abstract

We report two cases of hemophagocytic syndrome (HPS), a rare but fatal complication after living-donor liver transplantation (LDLT). Despite their recovery from pancytopenia following treatment with steroid pulse therapy, granulocyte stimulating factor, and intravenous γ-globulin, both patients died. The outcomes reported in cases published in English are devastating, with only 4 survivors among the total 14 patients including ours. Pancytopenia is frequently recognized postoperatively in liver transplant recipients, although its cause is difficult to establish. When pancytopenia accompanying persistent high fever is recognized in LDLT recipients, HPS should be suspected and bone marrow aspiration performed as promptly as possible because of the poor prognosis of this syndrome. There is still no optimal treatment for HPS after liver transplantation.

Entities:  

Mesh:

Year:  2011        PMID: 21969156     DOI: 10.1007/s00595-010-4512-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  25 in total

1.  Hemophagocytic syndrome after adult-to-adult living donor liver transplantation.

Authors:  N Akamatsu; Y Sugawara; S Tamura; Y Matsui; K Hasegawa; H Imamura; N Kokudo; M Makuuchi
Journal:  Transplant Proc       Date:  2006-06       Impact factor: 1.066

2.  Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis.

Authors:  Tomoko Henzan; Koji Nagafuji; Hiroshi Tsukamoto; Toshihiro Miyamoto; Hisashi Gondo; Shinsaku Imashuku; Mine Harada
Journal:  Am J Hematol       Date:  2006-01       Impact factor: 10.047

3.  G-CSF enhanced granulocyte production in a child with severe neutropenia in the setting of fatal virus-associated hemophagocytic syndrome.

Authors:  E Azuma; N Tabata; T Shibata; Y Komada; M Ito; S Atsumi; Y Kawasaki; M Ishii; M Sakurai
Journal:  Am J Hematol       Date:  1990-12       Impact factor: 10.047

4.  High-dose gamma-globulin therapy in the reactive haemophagocytic syndrome.

Authors:  D S Gill; A Spencer; R G Cobcroft
Journal:  Br J Haematol       Date:  1994-09       Impact factor: 6.998

5.  Present status of ABO-incompatible living donor liver transplantation in Japan.

Authors:  Hiroto Egawa; Satoshi Teramukai; Hironori Haga; Minoru Tanabe; Masanori Fukushima; Motohide Shimazu
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

6.  Haemophagocytic syndrome after liver transplantation in adults.

Authors:  Laura Lladó; Juan Figueras; Sonia Comí; Jaume Torras; Teresa Serrano; José Castellote; Eduardo Jaurrieta
Journal:  Transpl Int       Date:  2004-03-30       Impact factor: 3.782

Review 7.  Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature.

Authors:  Tracy I George; Michael Jeng; William Berquist; Athena M Cherry; Michael P Link; Daniel A Arber
Journal:  Pediatr Blood Cancer       Date:  2005-03       Impact factor: 3.167

8.  Successful treatment for a patient with hemophagocytic syndrome after a small-for-size graft liver transplantation.

Authors:  Tomoharu Yoshizumi; Akinobu Taketomi; Hiroto Kayashima; Noboru Harada; Hideaki Uchiyama; Yo-ichi Yamashita; Toru Ikegami; Yuji Soejima; Takashi Nishizaki; Mitsuo Shimada; Yoshihiko Maehara
Journal:  Hepatogastroenterology       Date:  2008 Mar-Apr

9.  Fatal hemophagocytic syndrome related to human herpesvirus-6 reinfection following liver transplantation: a case report.

Authors:  S Dharancy; V Crombe; M C Copin; E Boleslawski; L Bocket; N Declerck; V Canva; A Dewilde; P Mathurin; F R Pruvot
Journal:  Transplant Proc       Date:  2008-12       Impact factor: 1.066

10.  Hyperferritinemia in reactive hemophagocytic syndrome report of four adult cases.

Authors:  P R Koduri; G Carandang; P DeMarais; A R Patel
Journal:  Am J Hematol       Date:  1995-07       Impact factor: 10.047

View more
  3 in total

1.  Complete response to post-transplant lymphoproliferative disorder by surgical resection and rituximab after living-donor liver re-transplantation for recurrent primary sclerosing cholangitis.

Authors:  Koichiro Haruki; Hiroaki Shiba; Junichi Shimada; Norimitsu Okui; Tomonori Iida; Katsuhiko Yanaga
Journal:  Clin J Gastroenterol       Date:  2016-10-31

2.  Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature.

Authors:  Norifumi Iseda; Tomoharu Yoshizumi; Takeo Toshima; Akinari Morinaga; Takahiro Tomiyama; Junichi Takahashi; Takashi Motomura; Yohei Mano; Shinji Itoh; Noboru Harada; Toru Ikegami; Yuji Soejima
Journal:  Surg Case Rep       Date:  2018-08-29

3.  Comprehensive Analysis on the Specific Role and Function of Mitochondrial Inner Membrane Protein MPV17 in Liver Hepatocellular Carcinoma.

Authors:  Hanchuan Tao; Cheng Wang; Chongmei Lu; Ning Ma; Yifan Zhu; Shihai Xuan; Xiaojun Zhou
Journal:  Genet Res (Camb)       Date:  2022-07-19       Impact factor: 1.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.